NASDAQ : RMTI
Rockwell Medical, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 7.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 29.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Rockwell Medical, Inc. (RMTI) reported revenue of 69.39M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 69.39M | 69.26M | 101.49M | 83.61M | 72.81M | 61.93M |
| Cost of Revenue | 57.10M | 57.56M | 84.00M | 74.91M | 68.73M | 64.35M |
| Gross Profit | 12.29M | 11.70M | 17.48M | 8.70M | 4.08M | -2.42M |
| Selling, General & Admin | 16.77M | 16.39M | 16.86M | 14.27M | 17.74M | 21.08M |
| Research & Development | 40.00K | 19.00K | 1.11M | 3.12M | 6.83M | |
| Operating Expenses | 16.81M | 16.39M | 16.88M | 15.37M | 20.86M | 27.92M |
| Operating Income | -4.52M | -4.69M | 608.00K | -6.67M | -16.78M | -30.34M |
| Interest Expense | -1.13M | -1.12M | -1.25M | -2.30M | -1.94M | -2.36M |
| Interest & Investment Income | 176.00K | 234.00K | 92.00K | 211.00K | 33.00K | 22.00K |
| EBT Excluding Unusual Items | -5.48M | -5.58M | -554.00K | -8.76M | -18.68M | -32.67M |
| Gain (Loss) on Sale of Investments | 397.00K | 267.00K | 74.00K | 321.00K | 4.00K | |
| Pretax Income | -5.08M | -5.31M | -480.00K | -8.44M | -18.68M | -32.67M |
| Net Income | -5.08M | -5.31M | -480.00K | -8.44M | -18.68M | -32.67M |
| Preferred Dividends & Other Adjustments | 155.00K | 153.00K | 302.00K | 150.00K | ||
| Net Income to Common | -5.24M | -5.47M | -782.00K | -8.59M | -18.68M | -32.67M |
| Shares Outstanding (Basic) | 3.86M | 3.60M | 3.11M | 2.33M | 1.43M | 852.62K |
| Shares Outstanding (Diluted) | 3.86M | 3.60M | 3.11M | 2.33M | 1.43M | 852.62K |
| EPS (Basic) | -1.36 | -1.52 | -0.25 | -3.68 | -13.06 | -38.32 |
| EPS (Diluted) | -1.36 | -1.52 | -0.25 | -3.68 | -13.06 | -38.32 |
| Free Cash Flow | 1.54M | -1.20M | 3.19M | -9.70M | -17.21M | -34.06M |
| Free Cash Flow Per Share | 0.40 | -0.33 | 1.03 | -4.16 | -12.03 | -39.94 |
| Gross Margin | 17.71% | 16.89% | 17.23% | 10.41% | 5.60% | -3.91% |
| Operating Margin | -6.52% | -6.77% | 0.60% | -7.98% | -23.05% | -48.98% |
| Profit Margin | -7.55% | -7.89% | -0.77% | -10.27% | -25.65% | -52.76% |
| Free Cash Flow Margin | 2.22% | -1.73% | 3.14% | -11.60% | -23.64% | -54.99% |
| EBITDA | -2.43M | -2.50M | 2.79M | -5.23M | -16.20M | -29.67M |
| EBITDA Margin | -3.50% | -3.61% | 2.75% | -6.25% | -22.25% | -47.91% |
| D&A For EBITDA | 2.09M | 2.19M | 2.18M | 1.44M | 576.00K | 668.00K |
| EBIT | -4.52M | -4.69M | 608.00K | -6.67M | -16.78M | -30.34M |
| EBIT Margin | -6.52% | -6.77% | 0.60% | -7.98% | -23.05% | -48.98% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.52M | 10.71M | 15.66M | 8.98M | 10.10M | 13.28M |
| Short-Term Investments | 14.28M | 14.29M | 5.94M | 1.95M | 11.39M | 9.16M |
| Cash & Short-Term Investments | 24.80M | 25.00M | 21.60M | 10.94M | 21.49M | 22.44M |
| Accounts Receivable | 8.30M | 8.14M | 8.29M | 10.90M | 6.26M | 5.91M |
| Receivables | 8.30M | 8.14M | 8.29M | 10.90M | 6.26M | 5.91M |
| Inventory | 2.82M | 3.42M | 5.78M | 5.87M | 5.81M | 4.08M |
| Prepaid Expenses | 441.00K | 1.60M | 1.36M | 1.06M | 1.75M | 2.86M |
| Total Current Assets | 36.36M | 38.16M | 37.03M | 28.77M | 35.31M | 35.29M |
| Property, Plant & Equipment | 9.31M | 7.85M | 10.34M | 11.02M | 8.61M | 10.22M |
| Goodwill | 920.00K | 921.00K | 921.00K | 921.00K | 921.00K | 921.00K |
| Other Intangible Assets | 9.38M | 9.66M | 10.21M | 10.76M | ||
| Other Long-Term Assets | 556.00K | 556.00K | 706.00K | 705.00K | 1.80M | 2.14M |
| Total Assets | 56.53M | 57.15M | 59.21M | 52.17M | 46.63M | 48.57M |
| Accounts Payable | 3.18M | 2.00M | 2.87M | 4.52M | 4.05M | 3.74M |
| Accrued Expenses | 2.54M | 3.52M | 4.86M | 5.49M | 7.12M | 4.29M |
| Short-Term Debt | 264.00K | 268.00K | 244.00K | 503.00K | 437.00K | |
| Current Portion of Long-Term Debt | 1.77M | 1.63M | 7.38M | |||
| Current Portion of Leases | 1.90M | 1.62M | 2.17M | 1.94M | 2.00M | 2.00M |
| Current Unearned Revenue | 356.00K | 1.36M | 2.51M | 2.79M | 1.80M | 2.31M |
| Other Current Liabilities | 1.43M | 814.00K | 1.42M | 1.66M | 585.00K | 796.00K |
| Total Current Liabilities | 11.17M | 9.58M | 14.09M | 16.64M | 17.69M | 20.97M |
| Long-Term Debt | 7.24M | 8.83M | 8.47M | 8.29M | 7.55M | 13.19M |
| Long-Term Leases | 3.03M | 1.76M | 2.63M | 2.96M | 4.67M | 5.89M |
| Long-Term Unearned Revenue | 1.43M | 2.98M | 2.60M | 5.99M | ||
| Other Long-Term Liabilities | 14.00K | 14.00K | 14.00K | |||
| Total Liabilities | 21.44M | 20.16M | 26.62M | 30.88M | 32.53M | 46.04M |
| Common Stock | 4.00K | 3.00K | 3.00K | 1.00K | 1.00K | |
| Additional Paid-In Capital | 440.72M | 439.84M | 430.21M | 418.49M | 402.70M | 372.56M |
| Retained Earnings | -405.77M | -402.99M | -397.68M | -397.20M | -388.76M | -370.08M |
| Comprehensive Income & Other | 130.00K | 131.00K | 54.00K | -1.00K | 163.00K | 52.00K |
| Shareholders' Equity | 35.09M | 36.98M | 32.59M | 21.29M | 14.11M | 2.54M |
| Total Liabilities & Equity | 56.53M | 57.15M | 59.21M | 52.17M | 46.63M | 48.57M |
| Total Debt | 13.93M | 12.47M | 13.54M | 13.44M | 16.36M | 28.89M |
| Net Cash (Debt) | 10.86M | 12.53M | 8.07M | -2.50M | 5.13M | -6.46M |
| Net Cash Per Share | 2.81 | 3.48 | 2.60 | -1.07 | 3.59 | -7.57 |
| Filing Date Shares Outstanding | 4.03M | 3.94M | 3.41M | 2.93M | 1.26M | 854.42K |
| Total Common Shares Outstanding | 3.97M | 3.94M | 3.41M | 2.91M | 1.22M | 854.42K |
| Working Capital | 25.19M | 28.58M | 22.94M | 12.13M | 17.62M | 14.32M |
| Book Value Per Share | 8.83 | 9.38 | 9.57 | 7.31 | 11.60 | 2.97 |
| Tangible Book Value | 24.79M | 26.40M | 21.46M | 9.61M | 13.19M | 1.61M |
| Tangible Book Value Per Share | 6.24 | 6.70 | 6.30 | 3.30 | 10.84 | 1.89 |
| Machinery | 12.29M | 13.78M | 14.62M | 13.78M | 8.57M | 8.38M |
| Leasehold Improvements | 1.22M | 1.57M | 1.56M | 1.42M | 1.26M | 1.20M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -5.08M | -5.31M | -480.00K | -8.44M | -18.68M | -32.67M |
| Depreciation & Amortization | 2.09M | 2.19M | 2.18M | 1.44M | 576.00K | 2.52M |
| Other Amortization | 356.00K | 354.00K | 426.00K | 1.11M | 369.00K | 369.00K |
| Loss (Gain) From Sale of Assets | 146.00K | 57.00K | 1.00K | -3.00K | 8.00K | |
| Loss (Gain) From Sale of Investments | -397.00K | -267.00K | -74.00K | -321.00K | -4.00K | |
| Stock-Based Compensation | 1.87M | 1.82M | 1.29M | 932.00K | 315.00K | 943.00K |
| Other Operating Activities | 1.83M | 2.12M | 2.38M | 3.11M | 2.62M | 148.00K |
| Change in Accounts Receivable | -17.00K | -98.00K | 2.61M | -4.64M | -346.00K | -1.74M |
| Change in Inventory | 1.77M | 2.78M | -332.00K | 1.18M | -2.10M | -656.00K |
| Change in Accounts Payable | 1.68M | -870.00K | -1.65M | 463.00K | 314.00K | -416.00K |
| Change in Unearned Revenue | -475.00K | -46.00K | -3.81M | -3.83M | -2.03M | |
| Change in Other Net Operating Assets | -1.34M | -2.95M | -2.11M | -431.00K | 3.83M | 4.00K |
| Operating Cash Flow | 2.90M | -659.00K | 4.20M | -9.41M | -16.93M | -33.53M |
| Capital Expenditures | -1.36M | -542.00K | -1.01M | -284.00K | -281.00K | -522.00K |
| Sale of Property, Plant & Equipment | 175.00K | |||||
| Cash Acquisitions | -12.36M | |||||
| Investment in Securities | -7.87M | -8.00M | -3.85M | 9.60M | -2.12M | 833.00K |
| Investing Cash Flow | -9.05M | -8.54M | -4.87M | -3.04M | -2.40M | 311.00K |
| Short-Term Debt Repaid | -664.00K | -646.00K | -992.00K | -1.44M | -1.53M | |
| Long-Term Debt Repaid | -529.00K | -558.00K | -2.52M | -12.23M | -750.00K | |
| Total Debt Repaid | -1.13M | -1.19M | -1.20M | -3.51M | -13.68M | -2.28M |
| Net Debt Issued (Repaid) | -1.13M | -1.19M | -1.20M | -3.51M | -13.68M | -2.28M |
| Issuance of Common Stock | 7.82M | 7.82M | 10.18M | 14.86M | 15.02M | 107.00K |
| Repurchase of Common Stock | -6.00K | |||||
| Other Financing Activities | -2.50M | -2.37M | -1.63M | -5.00K | -191.00K | |
| Financing Cash Flow | 4.19M | 4.25M | 7.35M | 11.34M | 16.15M | -2.18M |
| Foreign Exchange Rate Adjustments | -5.00K | -4.00K | -3.00K | |||
| Net Cash Flow | -1.96M | -4.95M | 6.68M | -1.12M | -3.18M | -35.40M |
| Free Cash Flow | 1.54M | -1.20M | 3.19M | -9.70M | -17.21M | -34.06M |
| Free Cash Flow Margin | 2.22% | -1.73% | 3.14% | -11.60% | -23.64% | -54.99% |
| Free Cash Flow Per Share | 0.40 | -0.33 | 1.03 | -4.16 | -12.03 | -39.94 |
| Levered Free Cash Flow | 350.38K | -1.52M | 2.09M | -5.52M | -9.28M | -19.67M |
| Unlevered Free Cash Flow | 703.12K | -1.17M | 2.45M | -5.19M | -8.44M | -18.57M |
| Cash Interest Paid | 779.00K | 772.00K | 847.00K | 1.21M | 1.47M | 1.83M |
| Change in Working Capital | 2.08M | -1.61M | -1.53M | -7.24M | -2.13M | -4.84M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 27.97M | 32.84M | 65.93M | 53.85M | 11.81M | 38.53M |
| Enterprise Value | 17.11M | 22.26M | 61.83M | 56.99M | 6.51M | 34.92M |
| Last Close Price | 7.07 | 8.34 | 20.40 | 18.90 | 10.15 | 45.10 |
| Forward PE | 132.86 | 132.86 | 47.17 | 47.17 | 47.17 | |
| PS Ratio | 0.41 | 0.47 | 0.65 | 0.64 | 0.16 | 0.62 |
| PB Ratio | 0.80 | 0.89 | 2.02 | 2.53 | 0.84 | 15.20 |
| P/TBV Ratio | 1.15 | 1.24 | 3.07 | 5.60 | 0.90 | 23.87 |
| P/FCF Ratio | 18.50 | 20.66 | ||||
| P/OCF Ratio | 9.84 | 15.69 | ||||
| PEG Ratio | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | |
| EV/Sales Ratio | 0.25 | 0.32 | 0.61 | 0.68 | 0.09 | 0.56 |
| EV/EBITDA Ratio | 22.18 | |||||
| EV/EBIT Ratio | 101.70 | |||||
| EV/FCF Ratio | 11.45 | 19.38 | ||||
| Debt / Equity Ratio | 0.40 | 0.34 | 0.41 | 0.63 | 1.16 | 11.40 |
| Debt / EBITDA Ratio | 6,966.50 | 2.75 | ||||
| Debt / FCF Ratio | 9.05 | 4.24 | ||||
| Net Debt / Equity Ratio | -0.31 | -0.34 | -0.25 | 0.12 | -0.36 | 2.55 |
| Net Debt / EBITDA Ratio | 4.47 | 5.01 | -2.89 | -0.48 | 0.32 | -0.22 |
| Net Debt / FCF Ratio | -7.05 | 10.43 | -2.53 | -0.26 | 0.30 | -0.19 |
| Asset Turnover | 1.27 | 1.19 | 1.82 | 1.69 | 1.53 | 0.98 |
| Inventory Turnover | 16.37 | 12.51 | 14.42 | 12.82 | 13.90 | 16.11 |
| Quick Ratio | 2.96 | 3.46 | 2.12 | 1.31 | 1.57 | 1.35 |
| Current Ratio | 3.25 | 3.98 | 2.63 | 1.73 | 2.00 | 1.68 |
| Return on Equity (ROE) | -15.53% | -15.28% | -1.78% | -47.68% | -224.49% | -178.04% |
| Return on Assets (ROA) | -5.18% | -5.04% | 0.68% | -8.44% | -22.03% | -30.02% |
| Return on Capital Employed (ROCE) | -10.00% | -9.90% | 1.30% | -18.80% | -58.00% | -109.90% |
| Earnings Yield | -19.54% | -16.18% | -0.73% | -15.67% | -158.20% | -84.81% |
| FCF Yield | 5.40% | -3.66% | 4.84% | -18.01% | -145.76% | -88.40% |
| Buyback Yield / Dilution | -16.28% | -15.83% | -33.17% | -63.05% | -67.77% | -24.02% |